Histone Deacetylase Inhibitors Romidepsin and Vorinostat Promote Hepatitis B Virus Replication by Inducing Cell Cycle Arrest

BACKGROUND AND AIMS: Chronic hepatitis B virus (HBV) infection is a global public health challenge. HBV reactivation usually occurs in cancer patients after receiving cytotoxic chemotherapy or immunosuppressive therapies. Romidepsin (FK228) and vorinostat (SAHA) are histone deacetylase inhibitors (H...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yang, Yan, Yu, Chen, Zhen, Hu, Jie, Wang, Kai, Tang, Ni, Li, Xiaosong, Zhou, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111102/
https://www.ncbi.nlm.nih.gov/pubmed/34007797
http://dx.doi.org/10.14218/JCTH.2020.00105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111102/
https://www.ncbi.nlm.nih.gov/pubmed/34007797
http://dx.doi.org/10.14218/JCTH.2020.00105

Ejemplares similares